No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Zydus’ Pertuzumab Biosimilar to be Co-Marketed in India with Dr Reddy’s
On 28 June 2024, Zydus and Dr Reddy’s announced that they have entered a licensing agreement to co-market Zydus’ pertuzumab biosimilar in India. Dr Reddy’s receives semi-exclusive rights under the agreement, while Zydus will receive upfront and subsequent milestone...